Abdera Therapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
901 Gateway Blvd, South San Francisco, C...Phone Number
(778) 200-2999Website
www.abderatx.comRevenue
$10.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Abdera Therapeutics
Based in Vancouver, British Columbia, Abdera Therapeutics is a biopharmaceutical company with a focus on precision radiopharmaceuticals.Explore more
Abdera Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Abdera Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Abdera Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Abdera Therapeutics
Product Launch: Get notified when Abdera Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Abdera Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Abdera Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Abdera Therapeutics had a recent Job posting/layoffs
Check out if Abdera Therapeutics is spiking on competitors!
Earning: See what the market has to say on Abdera Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Abdera Therapeutics
Compare insights from companies similar to Abdera Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Abdera Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Abdera Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Abdera Therapeutics.
Abdera Therapeutics financials insights
Gather financial insights about Abdera Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series B
$142M
Abdera Therapeutics Tech Stack
A closer look at the technologies used by Abdera Therapeutics
Most Recent Scoops
Open Position
Open Position
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Open Position
Abdera Therapeutics News & Media
Abdera Therapeutics to Present Key Updates on its Radiopharmaceutical Development Pipeline at the 2025 American Association for Cancer Research (AACR) Annual Meeting
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable precision radiopharmaceuticals for cancer, today announced two upcoming presentations at the American Association for Cancer Research (AACR) Annual Meeting, being held from April 25 – 30, 2025 in Chicago, IL. These include: (1) a poster presentation of Abdera’s ongoing Phase 1 clinical trialAbdera Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable precision radiopharmaceuticals for cancer, today announced that Lori Lyons-Williams, president and chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. PT in San Francisco, CA. Ms. Lyons will detail the company’sTop 5 radiopharmaceuticals startups with VC backing - Outsourcing-Pharma.com
Meet the companies in the radiopharmaceuticals space attracting investor attentionAbdera Therapeutics Announces FDA Orphan Drug Designation for ABD-147 for the Treatment of Neuroendocrine Carcinoma
SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals for cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ABD-147 for the treatment of neuroendocrine carcinoma. ABD-147 is a next-generation precision radiopharmaceutical biologic therapy designed to deliver Actinium-225 (225
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Abdera Therapeutics
Sign Up For FreeTo access detailed company insights
Based in Vancouver, British Columbia, Abdera Therapeutics is a biopharmaceutical company with a focus on precision radiopharmaceuticals.... Read More
